On August 4, Monster Beverage declined 3.1% in regular trading, trading at $93.34/share, with turnover of $245 million. The stock came under pressure ahead of its Q2 earnings release scheduled for August 6, as analysts flagged rising hurdles for sustained growth in the second half.
UBS noted in a recent report that while Q2 organic sales growth is expected to reach 15.1%, above consensus, with international markets contributing approximately 25% growth, the company faces tougher year-over-year comparisons, fewer new product launches, and elevated valuation in H2 that could limit further upside. Deutsche Bank had previously downgraded the stock from Buy to Hold with a $98 price target. The consensus EPS estimate for Q2 stands at $0.59.
Within the Soft Drinks sector, the broader group traded lower. Among peers, Coca-Cola fell 0.92%, Pepsi declined 0.52%, Celsius Holdings dropped 2.43%, Keurig Dr Pepper lost 0.63%, and Coca-Cola Europacific fell 1.68%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments